Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOBIFI: Bifidobacteria for Infant Colic
NCT03219931Phase 4Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Oct 2013
- Primary completion
- Jul 2017
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 4 trial of Bifidobacterium breve B632, Bifidobacterium breve BR03, sponsored by Azienda Ospedaliero-Universitaria Maggiore della Carità. Started Oct 2013; status: completed.
02
Drugs
Bifidobacterium breve B632Bifidobacterium breve BR03
Beyond the preview
Go deeper on NCT03219931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03219931.